- Home
- TCBS vs BRNS Comparison
TCBS vs BRNS Comparison
Compare TCBS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBS
- BRNS
- Stock Information
- Founded
- TCBS 1934
- BRNS 2016
- Country
- TCBS United States
- BRNS United Kingdom
- Employees
- TCBS N/A
- BRNS N/A
- Industry
- TCBS Banks
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- TCBS Finance
- BRNS Health Care
- Exchange
- TCBS Nasdaq
- BRNS Nasdaq
- Market Cap
- TCBS 48.8M
- BRNS 36.0M
- IPO Year
- TCBS N/A
- BRNS 2021
- Fundamental
- Price
- TCBS $16.76
- BRNS $1.00
- Analyst Decision
- TCBS
- BRNS Strong Buy
- Analyst Count
- TCBS 0
- BRNS 1
- Target Price
- TCBS N/A
- BRNS $3.00
- AVG Volume (30 Days)
- TCBS 4.6K
- BRNS 17.8K
- Earning Date
- TCBS 08-12-2025
- BRNS 08-07-2025
- Dividend Yield
- TCBS 0.95%
- BRNS N/A
- EPS Growth
- TCBS N/A
- BRNS N/A
- EPS
- TCBS 0.68
- BRNS N/A
- Revenue
- TCBS $14,488,000.00
- BRNS $14,969,000.00
- Revenue This Year
- TCBS N/A
- BRNS N/A
- Revenue Next Year
- TCBS N/A
- BRNS N/A
- P/E Ratio
- TCBS $24.63
- BRNS N/A
- Revenue Growth
- TCBS 54.08
- BRNS 4381.74
- 52 Week Low
- TCBS $13.52
- BRNS $0.64
- 52 Week High
- TCBS $19.40
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- TCBS 65.38
- BRNS 55.94
- Support Level
- TCBS $16.20
- BRNS $0.90
- Resistance Level
- TCBS $19.40
- BRNS $1.10
- Average True Range (ATR)
- TCBS 0.51
- BRNS 0.06
- MACD
- TCBS 0.06
- BRNS 0.01
- Stochastic Oscillator
- TCBS 22.58
- BRNS 60.00
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.